The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm

Condition:   Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder Intervention:   Drug: Ruxolitinib Sponsor:   Seoul National University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials